
北美制药填充和表面处理外包市场预测至 2028 年 - COVID-19 影响和按成品状态(固体、半固体和液体)、内容(从动物源分离的有机物质、从微生物分离的有机物质、和无机物质)
No. of Pages: 126 | Report Code: TIPRE00027254 | Category: Life Sciences
No. of Pages: 126 | Report Code: TIPRE00027254 | Category: Life Sciences
Â
生物制药市场在北美继续扩大,并成为主要增长动力制药业。在接下来的重要几年里,生物制药市场将继续为制药市场提供重大的增长机会。由于流入该行业的资本不断增加,生物技术公司对选择合作的投资者变得更加挑剔,与以前现金投入的行业相比,他们的眼光更加长远。研发的烧钱率是众所周知的。过去两年,生物制药领域的融资和投资突破了历史最高水平。私人投资以健康科技和制药公司为主导,2020年上半年生物制药投资普遍同比增长。这是由强大的创新技术管道、处于高级研发阶段的新药、寻求抓住与该行业相关的更高投资回报的投资者的旺盛需求以及制药公司重新加载其管道的需要等因素推动的例如:2020 年 3 月,Thermo Fisher Scientific Inc. 投资了近 4.75 亿美元作为生物制药投资,用于扩大生物制剂、药品开发、细胞和基因治疗,并提高其在北方的商业能力美国。
中国爆发的 COVID-19 大流行严重影响了美国的成品药和原料药供应。据记录,2018 年,中国输往美国的进口线中估计有 83% 是人用制剂,而 7.5% 是原料药。此外,中国工厂的封锁和港口因冠状病毒措施而导致的物流延误将意味着产量下降和延误。向美国制造商运送 API。随着冠状病毒的传播,美国制药公司面临成本上升。因此,北美地区对 CMO 和制药公司的需求很高,并正在考虑获得预防 COVID-19 感染的临床试验疫苗的批准。
< p>借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动药品灌装和成品外包市场。北美药品灌装和包装外包市场预计在预测期内将以良好的复合年增长率增长。
Strategic insights for North America Pharmaceutical Fill and Finish Outsourcing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,188.8 Million |
Market Size by 2028 | US$ 1,741.0 Million |
Global CAGR (2021 - 2028) | 5.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 成品状态
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Pharmaceutical Fill and Finish Outsourcing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Pharmaceutical Fill and Finish Outsourcing Market is valued at US$ 1,188.8 Million in 2021, it is projected to reach US$ 1,741.0 Million by 2028.
As per our report North America Pharmaceutical Fill and Finish Outsourcing Market, the market size is valued at US$ 1,188.8 Million in 2021, projecting it to reach US$ 1,741.0 Million by 2028. This translates to a CAGR of approximately 5.6% during the forecast period.
The North America Pharmaceutical Fill and Finish Outsourcing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pharmaceutical Fill and Finish Outsourcing Market report:
The North America Pharmaceutical Fill and Finish Outsourcing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Pharmaceutical Fill and Finish Outsourcing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Pharmaceutical Fill and Finish Outsourcing Market value chain can benefit from the information contained in a comprehensive market report.